Adhesion molecules are required for development of hematopoietic stem and progenitor cells in the respective hematopoietic microenvironments. We previously showed that development of the erythroid progenitor cells is dependent on their direct adhesion to the stroma cells established from the erythropoietic organs. In this stroma-dependent erythropoiesis, we examined the role of adhesion molecules in erythropoiesis by blocking antibodies. The Successive studies showed the importance of RGD segm e n d and the CS-l region7,' of fibronectin as ligands for very late activation antigen-S (VLA-S) and VLA-4, respectively, and functional analysis showed that these integrins are responsible for proliferation and activation of lymphoc y t e~.~"~ Contrary to lymphoid organs, little is known about the role of the adhesion molecules in erythropoiesis. Recent studies showed that p1 integrins such as VLA-4 and VLA-5 are expressed on erythroid progenitor c e l i~'~. '~ and fibronectin was shown to be involved in the erythroleukemic cell adhesion to ECM.I5-IS Stromal-cell-associated-dependent erythropoie~is",~~ may provide an adequate experimental 
system to examine the functional cell adhesion molecules involved in erythropoiesis. We have developed an in vitro erythropoietic microenvironment using established stromal cells from mouse spleen"^" and fetal and demonstrated that direct cell-to-cell contact is required in addition to stem cell factor (SCF; a ligand for c-kit) and erythropoietin (EPO).'~ Using this in vitro erythropoietic system, we examined the possible role of the adhesion molecules in erythropoiesis.
MATERIALS AND METHODS
Erythroid colony formation. Mouse spleen stromal cell lines, M S 3 1 and MSS62, established from newborn C57BU6J mice?' were maintained in RITC80-725 (Kyokutou Pharmaceutical CO Ltd, Tokyo, Japan) supplemented with 2% fetal bovine serum (FBS), 0.02% bovine serum albumin (BSA), 10 pg/mL transferrin (Sigma, St Louis, MO), 1 pg/mL insulin (Shimizu Pharmaceutical CO Ltd, Shizuoka, Japan), and 10 ng/mL epidermal growth factor (EGF, recombinant; generously supplied by Wakunaga Pharmaceutical CO Ltd. Tokyo, Japan), as previously described.*' Cocultivation of erythroid progenitor cells on stromal cells was performed as described previously.2'-29 For the stroma-dependent colony formation of these cells, 2 X IO4 stroma cells were seeded to form a stromal layer in a 24-well plate (Falcon 3047; Becton Dickinson, Lincoln Park, NJ) 1 day before cocultivation. Erythroid progenitors prepared from livers of 13-day gestation C57BU6J micez6 were suspended in Iscove's modified Dulbecco's modification of Eagle's medium (IMDM; GIBCO, Grand Island, NY) with 30% heat-inactivated FBS, 0.4% methylcellulose, 1% BSA, 100 pmol/L 2-mercaptoethanol, and 0.1 UlmL Epo (recombinant; generously supplied by Kirin-Amgen CO Ltd, Tokyo, Japan), and cultured on the stromal cells with or without antibodies at a final concentration of 20 pg/mL. Four days after the cocultivation, colonies were stained with benzidine and the benzidine-positive colonies were scored. All cultures were incubated at 37°C in a humidified atmosphere of 5% CO2 in air.
Antibodies and peptides. Rat antibody PS12, which recognize mouse a 4 subunit of integrin VLA-4, and antibody M/K-2, which recognize mouse vascular cell adhesion molecule-l (VCAM-l), were gifts of Dr Kensuke Miyake (Saga Medical School, Saga, Japan). Both antibodies inhibit lymphopoiesis in long-term bone marrow culture." A hamster monoclonal antibody (MoAb) HMa5-l, which recognizes mouse a 5 subunit of integrin VLA-5, was established from a hamster-mouse heterohybridoma and blocks the adhesion of mast cell line completely and erythroleukemia cell line partially to fibronectin substrata (Yagita, manuscript in preparation). The RGD peptide'' (GRGDSP peptides; TELIOS Pharmaceutical Inc, San In previous studies. we shmved t h a t stro- For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From mal cells established from the erythropoietic tissues can support large erythroid colony
To evaluate the possible function of @ l integrins in erythroid progenitor cells, the inhibitory effect of specific MoAbs to VLA-4 and VLA-5 integrins on the large erythroid colony formation was examined using spleen stromal (MSS31 and 62) cells and 13-day-old fetal liver cells containing erythroid and granulohonocytic progenitor cells. Formation of the large erythroid colonies after 4 days of culture (Fig IC) was inhibited by the addition of anti-VLA-4 antibody (Fig ID) . Contrary to its inhibition of the large erythroid colony formation, adhesion and formation of the granulohonocytic colonies ( Fig 1A) were not inhibited by anti-VLA-4 antibody ( Fig  IB) .
Based on this result, we examined quantitatively the inhibitory effect of MoAbs against two integrins, VLA-4 and V L A J (Fig 2) . The large erythroid colony formation was reproducibly inhibited by anti-VLA-4 antibody, but not by anti-VLA-5 antibody. The inhibitory activities of anti-VLA-4 antibody were saturated at the concentration of 50 pg/mL, but anti-VLA-5 antibody had no effect even at the concentration of 50 pg/mL (data not shown).
Expression of jbronectin and VCAM-I in the stromal cells. Inhibitory effect of anti-VLA-4 antibody on the large colony formation supported by the stromal cells strongly suggested the presence of ligand molecules for this integrin in the stromal cells. Because fibronectin and VCAM-1 are known ligands for VLA-4 integrin, the presence of both molecules was analyzed by flow cytometrical detection (Fig 3) . Because an excess EDTA treatment of MSS cells did not decrease fluorescence intensities, fibronectin detected in this analysis may be caused by the cell-bound forms. Thus, MSS cells abundantly expressed both ligand molecules.
Involvement of VCAM-I in the large erythroid colony formation. Functional roles of the ligand molecules for the integrins were examined by the inhibitory activities of anti-VCAM-l antibody and the synthetic peptides carrying the binding domains of fibronectin to the integrins. Anti-VCAM-I antibody showed a partial inhibition (30% to 50%) in its concentration that completely blocked lymphopoiesis," whereas anti-VLA-4 antibody almost completely inhibited (80% to 90%) the large erythroid colony formation (Fig 2) .
Because fibronectin contains ligand domains for both VLA-4 and V L A J integrins, involvement of fibronectin was examined using known CS-l and RGD sequences recognized by both integrins ( Table 1) . When these peptides were added to the culture of erythroid progenitor cells on the MSS62 monolayers, dose-dependent inhibition of the large erythroid colony formation was not observed except at highest concentration (80 pg/mL) of CS-l peptide. This is contrary to its inhibitory effect observed in lymphocyte proliferation in which 50 pg/mL synthetic peptides may be a sufficient amount." A high dose of CS-I peptide caused growth suppression and morphologic change of MSS cells; thus, the fibronectin CS-l sequence seems to have a critical role in the maintenance of adhesion and cell proliferation of MSS cells. With such a toxic effect, MSS cells could not provide an adequate microenvironment for erythroid progenitor cells. For 
VCAM-1 fibronectin
Similarly, RGD peptide had no inhibitory effect. When CS-1 peptide was added with either anti-VCAM-1 antibody or anti-VLAJ antibody, no additive effect was observed. Thus, the CS-l sequence of fibronectin may not act as a major ligand for VLA-4 integrin in the erythropoietic microenvironment. Anti-VU-4 antibody blocks binding of erythroid cells to the stroml cells. Because the above studies showed that pressed in TSA8 cells. VLA-4 is more abundant than VLA-S and this pattern of expression is essentially similar to that observed in the early erythroid progenitor cells.'" The binding assay was performed in the presence or absence of anti-VLA-4. anti-VLA-S. anti-VCAM-I, CS-l, and RGD peptides (Fig S) . Inhibitory activities of these agents on the binding assay were essentially the same as observed in the large erythroid colony formation assay (Fig 2) . Anti-VLA-4 antibody dramatically inhibited the binding of TSA8 cells to MSS3 1 cells. but anti-VLA-S blocked their binding only 15%-to 20%. Anti-VCAM-I antibody partially inhibited the binding. whereas the binding was not inhibited by either CS-1 or R G D peptide. We then examined the effect of these antibodies on the adhesion of the fetal liver erythroid progenitor cells (CFU-E) to the stroma cells by measuring the CFU-E colony formation ( Table 2 ). The conventional CFU-E colonies were formed in the semisolid culture for 2 days on the stromal cells as previously reported" and these stromaindependent CFU-E colonies were not affected by the addition of antibodies and peptides (Table 2 . left column). After the fetal liver progenitor cells adhered to MSS62 cells for 2 hours. the nonadherent cells were recovered and the CFU-E colonies were formed. Approximately half of the CFU-E colony-forming cells were adhered to MSS62 cells. Anti-VLA-4 most strongly inhibited the adhesion of the CFU-E colony-forming cells. whereas anti-VLAS and anti-VCAM-I inhibited adhesion weakly. These results were consistent with those of TSAW cells. However, R G D peptide strongly inhibited their adhesion, whereas CS-! peptide did not. although both peptides did not inhibit the large erythroid colony formation on the stromal cells.
DISCUSSION
Hematopoietic stem cells and their progenitor cells can proliferate and differentiate in a microenvironment of bone marrow, spleen, and fetal liver. We previously established stromal cell lines from fetal liver (FLS cells), which is a major erythropoietic organ. and from newborn spleen (MSS cells), in which the stem cells are predominantly committed to erythroid development. As expected. these stromal cells supported erythropoiesis in
The large erythroid colonies were formed from 13-day-old fetal liver erythroid progenitor cells in a semisolid medium in the presence of Epo under direct cell contact with the stromal cell layers. We have shown that production of SCF, a ligand for c-kit. is essential for the stroma pported erythropoiesis,'" but another factor(s) is expect1 o be required for the direct cellto-cell adhesion. becaust m y stromal cell lines producing SCF abundantly did not ~~p p o r t erythropoiesis. The integrin family may be the most probable candidate(s) for such an adhesion molecule(s) required for erythropoiesis. because the importance of their adhesive interactions in lymphopoiesis has been well studied.'' In the present study, we examined functional roles of the Dl integrin subfamily, VLA-4 and VLA-S, because both integrins are expressed in erythroid progenitors of bone marrows'' and fetal livers" and tibronectin was shown to provide adhesive ligands for the erythroid cell^.'^"' We found that murine erythroleukemic cells (TSA8). which can be induced tor ard Epo-re- For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From sponsive erythroid progenitor cells29~30 corresponding to CFU-E, abundantly expressed VLA-4 and VLAJ (Fig 4) . However, the quantitative binding assay indicated that VLA-4 is mostly involved in the binding of TSAS cells to MSS stromal cell layers. The adhesion of the fetal liver CFU-E colony-forming cells to the stromal cells showed essentially similar result with that of TSAS cells (Table 2) , and the large colony formation of the fetal liver erythroid progenitor cells on the stromal cell layers was inhibited by anti-VLA-4, but not by anti-VLAJ, antibody. These results clearly indicate that VLA-4, but not VLA-5, is essential for a rapid expansion of the erythroid progenitor cells in the erythropoietic microenvironments such as fetal liver and spleen. This is consistent with the report by Simmons et a13' that human erythroid progenitors (BFU-E) bind to stromal cells via Both integrins share the same p 1 subunit, but differ in a subunits. VLA-4 recognizes fibronectin by CS-l peptide domain, whereas VLA-4 recognizes fibronectin by RGD peptide domain. Anti-VLA-5 antibody was reported to block attachment of both CFU-E and proerythroblasts to fibronectin," and it partially blocked the adhesion of the progenitor cells to the stroma cells (Table 2) ; thus, VLA-5 integrin expressed in the erythroid progenitor cells may be functional. We found that adhesion of the CFU-E colonyforming cells was inhibited by RGD peptide ( Table 2) , whereas it did not affect the large erythroid colony formation ( Table 1 ). In addition, we have tried to culture the fetal liver erythroid progenitor cells on bovine native fibronectincoated dishes for the simple reconstitution of the stromal cell functions, but did not observe formation of the large erythroid colonies (data not shown). Thus, VLA-5 and fibronectin could mediate adhesion of the erythroid progenitor cells to the stromal cells, but the adhesion itself may not be sufficient for the stroma-supported erythropoiesis. Our results demonstrated that binding of the erythroid progenitor cells to the stromal cells may be separated from their successive rapid proliferation in the erythropoietic tissues. It was reported recently that another integrin, (u4p7, is involved in binding to both fibronectin and VCA"l.32 We could not observe the expression of a4P7 on TSA8 and fetal liver progenitor cells (c-kit-positiveflineage-negative) by flow cytometry (Yagita, unpublished observation). It seems probable that a4p7 is not involved in erythropoiesis.
Whereas fibronectin is the only known ligand for VLA-5, VLA-4 has more redundant ligands, such as VCA"1, which is involved in adhesion of B cells to germinal centers33 and in adhesion of leukocytes to activated end~thelium.".~~ Partial inhibition of binding of TSAS cells (Fig 5) as well as CFU-E colony-forming cells (Table 2 ) and the large erythroid colony formation on the stromal cells (Fig 2) For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From
